Determinazione nr. 2360 del 27/07/2023
NULLAOSTA ALL’AVVIO DELLO STUDIO CLINICO DENOMINATA DSE-BPM-01-20EU MILOS “NON-INTERVENTIONAL STUDY ON THE TREATMENT WITH BEMPEDOIC ACID AND/OR ITS FIXED-DOSE COMBINATION WITH EZETIMIBE IN ROUTINE CLINICAL PRACTICE IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA”, DA EFFETTUARSI PRESSO L’U.O. CARDIOLOGIA DI RAVENNA E CONTESTUALE APPROVAZIONE DELLA CONVENZIONE PER SPERIMENTAZIONE.
Pdf
Stampa
Provvedimento
27-07-2023
Determinazione nr. 2360 del 27/07/2023
NULLAOSTA ALL’AVVIO DELLO STUDIO CLINICO DENOMINATA DSE-BPM-01-20EU MILOS “NON-INTERVENTIONAL STUDY ON THE TREATMENT WITH BEMPEDOIC ACID AND/OR ITS FIXED-DOSE COMBINATION WITH EZETIMIBE IN ROUTINE CLINICAL PRACTICE IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA”, DA EFFETTUARSI PRESSO L’U.O. CARDIOLOGIA DI RAVENNA E CONTESTUALE APPROVAZIONE DELLA CONVENZIONE PER SPERIMENTAZIONE.
NULLAOSTA ALL’AVVIO DELLO STUDIO CLINICO DENOMINATA DSE-BPM-01-20EU MILOS “NON-INTERVENTIONAL STUDY ON THE TREATMENT WITH BEMPEDOIC ACID AND/OR ITS FIXED-DOSE COMBINATION WITH EZETIMIBE IN ROUTINE CLINICAL PRACTICE IN PATIENTS WITH PRIMARY HYPERCHOLESTERO
nessuna
27-07-2023